Showing 1 - 20 results of 82 for search '(( significantly ((lower decrease) OR (mean decrease)) ) OR ( significantly reported decrease ))~', query time: 0.59s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    “…In addition, the mean aspartate aminotransferase-to-platelet ratio index (APRI) decreased during letrozole treatment; the values at 18 and 24 months were significantly lower than those at baseline (p = 0.024 and p = 0.026). …”
  6. 6

    S1 Data - by Kazuyoshi Ohkawa (836847)

    Published 2024
    “…In addition, the mean aspartate aminotransferase-to-platelet ratio index (APRI) decreased during letrozole treatment; the values at 18 and 24 months were significantly lower than those at baseline (p = 0.024 and p = 0.026). …”
  7. 7
  8. 8

    Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. by Livia Vignozzi (22430567)

    Published 2025
    “…<b>E</b>, Quantification of the average firing rate of the recorded PV-INs in response to optogenetic stimulation. A significant decrease in firing activity is evident in stroke animals (Two-tailed <i>T</i> Test *** <i><i>P</i></i> < 0.001). …”
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Characteristics of the included studies. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  14. 14

    Summary of results. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  15. 15

    Bias risk assessments for each RCT study. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  16. 16

    The flow chart of studies selecting. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  17. 17

    Funnel plots for intraoperative blood loss. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  18. 18

    Bias risk assessments for each RCS study. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  19. 19

    Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

    Published 2025
    “…</p><p>Results</p><p>Among 1,360 participants with T2DM, the mean sleep duration was 6.45 ± 1.95 hours. During follow-up, 237 (17.43%) participants reported new-onset CVD. …”
  20. 20